Categories: EHRHealthcareNews

2024 Surescripts White Coat Award Recognizes 10 Healthcare Technology Leaders in Performance, Innovation and Accuracy

ARLINGTON, Va.–(BUSINESS WIRE)–#HealthIT–Surescripts®, the nation’s leading health information network, awarded the 2024 Surescripts White Coat Award™ to 10 healthcare industry leaders, recognizing their commitment to performance, innovation and accuracy.


The 2024 Surescripts White Coat Award winners achieved excellence across three categories, including Highest Performance, Innovation and RxChange Champion. This year’s winners include the following leaders from across healthcare:

  1. athenahealth
  2. Cleveland Clinic
  3. CVS Pharmacy
  4. DAW Systems, Inc. (ScriptSure)
  5. Epic
  6. Greenway HealthTM
  7. Hamilton Health Care System
  8. Lexington Medical Center
  9. SRS Pharmacy Systems
  10. Walmart

“We are thrilled to recognize the 2024 White Coat Award recipients for continually raising the bar for accuracy, adopting best practices and technology enhancements that ensure clinicians are equipped to provide quality, safe and effective care that their patients deserve,” said Frank Harvey, Chief Executive Officer for Surescripts. “For more than two decades, the Surescripts Network Alliance has continued to prioritize accuracy and patient safety for the billions of e-prescriptions processed each year. This commitment means prescribers and pharmacists are spending less time clarifying the prescriber’s intent and more time focused on what matters most – the patients in their care.”

The 2024 Surescripts White Coat Award recognizes health systems, pharmacies, pharmacy technology vendors and electronic health records (EHR) vendors that help deliver clear and accurate electronic prescriptions, eliminate confusion and time-consuming phone calls and faxes, and give patients better access to the medications they need. Winners are recognized for excellence in three categories:

  • Highest Performance: best overall performance score across e-prescriptions
  • RxChange Champion: successfully advancing the RxChange transaction, which lets pharmacies communicate with prescribers to resolve prescription concerns within their electronic workflow.
  • Innovation: driving performance optimization across the healthcare continuum, ensuring prescribers and pharmacists can provide quality care to patients in a timely manner.

In 2023, Surescripts processed 2.5 billion e-prescriptions, 204.1 million CancelRx Requests and 34.6 million RxChange Requests.

Surescripts continues to improve electronic prescribing with innovations like Sig IQ technology that translates free-text patient directions into a quality-controlled, clinically validated format in order to protect prescriber intent and patient safety. This capability was originally developed to enhance medication histories, Sig IQ expanded to add a Structured & Codified Sig to 1.4 million RxRenewal Requests sent by pharmacies in Q4 2023, allowing prescribers to approve these requests in fewer keystrokes.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we align healthcare organizations across the nation and convene the Surescripts Network Alliance® to give healthcare professionals the trusted insights they need to serve patients. Together, we’re making interoperability an everyday reality, making it simpler to choose medications patients can afford and adhere to, and getting specialty medications to patients more efficiently. Visit us at surescripts.com and follow us on LinkedIn.

Contacts

Kate Giaquinto

Surescripts

(571) 290-6859

Kate.Giaquinto@surescripts.com

Staff

Recent Posts

Laurel Bridge Software Advances Medical Imaging Workflow With New AI and Cloud Innovations at RSNA 2024

NEWARK, DE / ACCESSWIRE / November 22, 2024 / Laurel Bridge Software, a leader in…

2 hours ago

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or…

2 hours ago

Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting

Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New…

2 hours ago

Sunshine Biopharma Launches a New Generic Prescription Drug

FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the…

2 hours ago